The Current Burden of Hepatitis B in the United States: A State, Territorial, and County Modelling Analysis
Devin Razavi‐Shearer(University of Health Sciences Antigua), Homie Razavi(Center for Disease Analysis), Samantha Hall(Center for Disease Analysis), Robert G. Gish(California Pacific Medical Center), Thaddeus Pham(Hawaii Department of Health), Kathryn Razavi‐Shearer(Center for Disease Analysis), Chari Cohen(Hepatitis B Foundation), Alexis Voeller(Center for Disease Analysis), William Remak(Sonoma Technology (United States)), Myriam Saboui(Hawaii Department of Health), C. K. Wallace(Center for Disease Analysis), Ivane Gamkrelidze
Cited by 1
Related Papers
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Global epidemiology and genotype distribution of the hepatitis C virus infection
|Journal of Hepatology|2014|1.9k
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484